165 related articles for article (PubMed ID: 37632647)
1. A high affinity and specificity anti-HER2 single-domain antibody (VHH) that targets trastuzumab's epitope with versatile biochemical, biological, and medical applications.
Nikkhoi SK; Heydarzadeh H; Vandavasi VG; Yang G; Louro P; Polunas M; Owji H; Hatefi A
Immunol Res; 2024 Feb; 72(1):103-118. PubMed ID: 37632647
[TBL] [Abstract][Full Text] [Related]
2. Bispecific killer cell engager with high affinity and specificity toward CD16a on NK cells for cancer immunotherapy.
Nikkhoi SK; Li G; Eleya S; Yang G; Vandavasi VG; Hatefi A
Front Immunol; 2022; 13():1039969. PubMed ID: 36685519
[TBL] [Abstract][Full Text] [Related]
3. Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery.
Kijanka M; Warnders FJ; El Khattabi M; Lub-de Hooge M; van Dam GM; Ntziachristos V; de Vries L; Oliveira S; van Bergen En Henegouwen PM
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1718-29. PubMed ID: 23778558
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of camelid single-domain antibodies against HER2.
Hussack G; Raphael S; Lowden MJ; Henry KA
BMC Res Notes; 2018 Dec; 11(1):866. PubMed ID: 30518413
[TBL] [Abstract][Full Text] [Related]
5. Multivalent targeting and killing of HER2 overexpressing breast carcinoma cells with methotrexate-encapsulated tetra-specific non-overlapping variable domain heavy chain anti-HER2 antibody-PEG-liposomes: In vitro proof-of-concept.
Khoshtinat Nikkhoi S; Rahbarizadeh F; Ahmadvand D; Moghimi SM
Eur J Pharm Sci; 2018 Sep; 122():42-50. PubMed ID: 29933078
[TBL] [Abstract][Full Text] [Related]
6. T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: towards tumor-directed oligoclonal T cell therapy.
Jamnani FR; Rahbarizadeh F; Shokrgozar MA; Mahboudi F; Ahmadvand D; Sharifzadeh Z; Parhamifar L; Moghimi SM
Biochim Biophys Acta; 2014 Jan; 1840(1):378-86. PubMed ID: 24076235
[TBL] [Abstract][Full Text] [Related]
7. A novel nanobody-based HER2-targeting antibody exhibits potent synergistic antitumor efficacy in trastuzumab-resistant cancer cells.
Liu X; Luan L; Liu X; Jiang D; Deng J; Xu J; Yuan Y; Xing J; Chen B; Xing D; Huang H
Front Immunol; 2023; 14():1292839. PubMed ID: 37954614
[TBL] [Abstract][Full Text] [Related]
8. VHH characterization. Comparison of recombinant with chemically synthesized anti-HER2 VHH.
Hartmann L; Botzanowski T; Galibert M; Jullian M; Chabrol E; Zeder-Lutz G; Kugler V; Stojko J; Strub JM; Ferry G; Frankiewicz L; Puget K; Wagner R; Cianférani S; Boutin JA
Protein Sci; 2019 Oct; 28(10):1865-1879. PubMed ID: 31423659
[TBL] [Abstract][Full Text] [Related]
9. Oligo-clonal nanobodies as an innovative targeting agent for cancer therapy: New biology and novel targeting systems.
Nikkhoi SK; Rahbarizadeh F; Ahmadvand D
Protein Expr Purif; 2017 Jan; 129():115-121. PubMed ID: 27693491
[TBL] [Abstract][Full Text] [Related]
10. Liposomal nanoparticle armed with bivalent bispecific single-domain antibodies, novel weapon in HER2 positive cancerous cell lines targeting.
Nikkhoi SK; Rahbarizadeh F; Ranjbar S; Khaleghi S; Farasat A
Mol Immunol; 2018 Apr; 96():98-109. PubMed ID: 29549861
[TBL] [Abstract][Full Text] [Related]
11. Isolation and Characterization of Single-Domain Antibodies from Immune Phage Display Libraries.
Rossotti MA; Trempe F; van Faassen H; Hussack G; Arbabi-Ghahroudi M
Methods Mol Biol; 2023; 2702():107-147. PubMed ID: 37679618
[TBL] [Abstract][Full Text] [Related]
12. Characterization of novel CD19-specific VHHs isolated from a camelid immune library by phage display.
Ganji M; Safarzadeh Kozani P; Rahbarizadeh F
J Transl Med; 2023 Dec; 21(1):891. PubMed ID: 38066569
[TBL] [Abstract][Full Text] [Related]
13. Biparatopic single-domain antibodies against Axl achieve ultra-high affinity through intramolecular engagement.
Henry KA; Nguyen TD; Baral TN; Hussack G; Raphael S; Arbabi-Ghahroudi M; Robert A; Durocher Y; Wu C; Jaramillo ML; MacKenzie CR
Biochem Biophys Res Commun; 2021 Jul; 562():154-161. PubMed ID: 34058562
[TBL] [Abstract][Full Text] [Related]
14. A Diverse Set of Single-domain Antibodies (VHHs) against the Anthrax Toxin Lethal and Edema Factors Provides a Basis for Construction of a Bispecific Agent That Protects against Anthrax Infection.
Vrentas CE; Moayeri M; Keefer AB; Greaney AJ; Tremblay J; O'Mard D; Leppla SH; Shoemaker CB
J Biol Chem; 2016 Oct; 291(41):21596-21606. PubMed ID: 27539858
[TBL] [Abstract][Full Text] [Related]
15. Expression and In Vitro Function of Anti-Breast Cancer Llama-Based Single Domain Antibody VHH Expressed in Tobacco Plants.
Park SR; Lee JH; Kim K; Kim TM; Lee SH; Choo YK; Kim KS; Ko K
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079309
[TBL] [Abstract][Full Text] [Related]
16. An alpaca single-domain antibody (VHH) phage display library constructed by CDR shuffling provided high-affinity VHHs against desired protein antigens.
Tsukahara N; Murakami A; Motohashi M; Nakayama H; Kondo Y; Ito Y; Azuma T; Kishimoto H
Int Immunol; 2022 Jul; 34(8):421-434. PubMed ID: 35689594
[TBL] [Abstract][Full Text] [Related]
17. Biochemistry, structure, and cellular internalization of a four nanobody-bearing Fc dimer.
Chabrol E; Fagnen C; Landron S; Marcheteau E; Stojko J; Guenin SP; Antoine M; Fould B; Ferry G; Boutin JA; Vénien-Bryan C
Protein Sci; 2021 Sep; 30(9):1946-1957. PubMed ID: 34117809
[TBL] [Abstract][Full Text] [Related]
18. VHH characterization.Recombinant VHHs: Production, characterization and affinity.
Chabrol E; Stojko J; Nicolas A; Botzanowski T; Fould B; Antoine M; Cianférani S; Ferry G; Boutin JA
Anal Biochem; 2020 Jan; 589():113491. PubMed ID: 31676284
[TBL] [Abstract][Full Text] [Related]
19. Selection and identification of single-domain antibody fragment against capsid protein of porcine circovirus type 2 (PCV2) from C. bactrianus.
Yang S; Shang Y; Yin S; Tian H; Chen Y; Sun S; Jin Y; Liu X
Vet Immunol Immunopathol; 2014 Jul; 160(1-2):12-9. PubMed ID: 24736187
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties.
Nordstrom JL; Gorlatov S; Zhang W; Yang Y; Huang L; Burke S; Li H; Ciccarone V; Zhang T; Stavenhagen J; Koenig S; Stewart SJ; Moore PA; Johnson S; Bonvini E
Breast Cancer Res; 2011; 13(6):R123. PubMed ID: 22129105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
